Careers  |  Sign In  |  Register

Latest in Hematology-Oncology

Reuters Health • The Doctor's Channel Daily Newscast

Temsirolimus effective in some cases of heavily treated mantle cell lymphoma

NEW YORK (Reuters Health) - A phase III clinical trial comparing treatments for relapsed or refractory mantle cell lymphoma indicates that temsirolimus (Wyeth Pharmaceuticals, Philadelphia) significantly improves progression-free survival and objective response rates, compared with established...

Reuters Health • The Doctor's Channel Daily Newscast

Cases of leukoencephalopathy associated with rituximab therapy

NEW YORK (Reuters Health) - Rituximab (Rituxan) has been implicated in 57 cases of progressive multifocal leukoencephalopathy (PML) in HIV-negative patients diagnosed with hematologic malignancies or autoimmune diseases, since the drug was approved by the US Food and Drug Administration in 1997 until the...

Reuters Health • The Doctor's Channel Daily Newscast

Stem cell transplant capable of reversing type 1 diabetes

NEW YORK (Reuters Health) - In patients with newly diagnosed type 1 diabetes, high-dose immune ablation followed by autologous nonmyeloablative hematopoietic stem cell transplantation (HSCT) induces significant and lasting improvement in beta cell function, often leading to insulin independence, results of a...